GLP-1 receptor agonist therapy represents one of the most significant advances in medical weight loss and metabolic optimization, not because it's a quick fix, but because it works by addressing the underlying biological drivers of weight gain, appetite dysregulation, and cardiometabolic disease
Most studies on NAC have been done on non-pregnant individuals, so there is limited data on the potential effects of NAC on developing fetuses
May benefit if you: Approach with caution / avoid if you: A pre-treatment consultation and functional medicine assessment is essential before starting
Deoxycholate (DC) promotes fat cell digestion (1) by disrupting their cellular structure
Should circumstances around insurance coverage or pricing change in the coming months or years, there may be an increase in GLP-1 weight loss users and longer periods of compliance
Ferrostatin-1 ameliorated oxidative lipid damage in LPS-induced acute lung injury